This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Toy EL, Vekeman F, Laliberté F, Dority B, Perlman D, Barghout V, Duh MS, Heaney ML.Comparison of infection-related hospitalization risk and associated costs among patients receiving sargramostim (Leukine Rm), filgrastim (Neupogen Rm), and pegfilgrastim (Neulasta Rm) for chemotherapy-induced neutropenia. 50th Annual Meeting and Exposition of the American Society of Hematology: abstr. 665, 8 Dec 2008. Available from: URL: http://www.hematology.org
Rights and permissions
About this article
Cite this article
Sargramostim best choice in neutropenia. Pharmacoecon. Outcomes News 569, 7 (2009). https://doi.org/10.2165/00151234-200905690-00014
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905690-00014